Mpox is a rare, but potentially serious, viral illness that typically involves flu-like symptoms, swollen lymph nodes and a ...

The Department of Disease Control (DDC) has begun administering monkeypox (Mpox) vaccinations to medical personnel.Dr Panumas Yanawetsakul, DDC Director-General, said the department has received 2,220 ...

A recent study carried out at Charité Universitätsmedizin Berlin and published in The Lancet Infectious Diseases has shown that one dose of Bavarian Nordic’s Jynneos (smallpox and mpox vaccine ...

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ...

The vaccine—called Jynneos in the US and Imvanex in Europe—has not been made or sold in Africa so far. And at US$100 per dose ...

“Even in light of these promising data, we strongly recommend people receive two doses of Jynneos vaccine spaced out 28 days apart to ensure durable, lasting immune protection against monkeypox ...

Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S.

Also, their recently FDA-approved freeze-dried Jynneos vaccine and EU/US-approved chikungunya vaccine launches are near-term growth catalysts. BVNKF’s 2025 outlook also suggests they still have ...

Health officials are advising people at higher risk of mpox infection to consider being vaccinated with two doses of the JYNNEOS vaccine, which is available statewide. Laboratory testing of the ...

The company said the newly approved formulation of its vaccine, Jynneos, provides advantages in terms of transportation, storage conditions and shelf life, which are important factors for long ...